ArticleThe Journal of international medical research2026
Prognostic utility of the serum uric acid-to-high-density lipoprotein cholesterol ratio following hepatectomy for hepatocellular carcinoma.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo evaluate the prognostic value of the uric acid-to-high-density lipoprotein cholesterol ratio in predicting postoperative survival in patients with hepatocellular carcinoma and to develop a nomogram to assist in clinical decision-making and patient management.MethodsA total of 422 patients who underwent hepatectomy at Meizhou People's Hospital between May 2011 and January 2023 were included. The optimal cutoff value for uric acid-to-high-density lipoprotein cholesterol ratio was determined using the R package 'survminer,' and patients were stratified into two groups accordingly. The prognostic significance of uric acid-to-high-density lipoprotein cholesterol ratio was evaluated using Kaplan-Meier survival analysis and Cox proportional hazards regression models. A prognostic nomogram was subsequently constructed. The predictive performance of the nomogram was assessed using the concordance index, and its clinical utility was evaluated via decision curve analysis.ResultsThe optimal cutoff value for uric acid-to-high-density lipoprotein cholesterol ratio was 253.9. Survival analysis demonstrated significantly longer survival in the low-uric acid-to-high-density lipoprotein cholesterol ratio group. Cox regression analysis identified uric acid-to-high-density lipoprotein cholesterol ratio, advanced lung cancer inflammation index, and tumor-node-metastasis classification stage as independent prognostic factors for postoperative survival in patients with hepatocellular carcinoma. A predictive nomogram incorporating these variables was developed and validated using calibration curves, time-dependent receiver operating characteristic analysis, and decision curve analysis. The results confirmed that the nomogram demonstrated superior predictive accuracy and greater net benefit compared with models based on any of the individual variables alone.ConclusionsUric acid-to-high-density lipoprotein cholesterol ratio may serve as a potential prognostic biomarker for postoperative survival in patients with hepatocellular carcinoma. The established nomogram may provide a practical tool for prognostic assessment in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.